Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceu Recall: Lidocaine HCL (PF) Injection, L
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceu Recall: Lidocaine HCL (PF) Injection, L is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical; Product: Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF) 40 MG/ML INJECTABLE, For ocul
| Recalling firm | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical |
|---|---|
| Product | Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF) 40 MG/ML INJECTABLE, For ocular injection, Preservative free, discard unused portion, protect from light, 5 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1011-5 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic |
| Recall initiated | 20200115 |
| Recall number | D-0962-2020 |
| Category | drug |
| State | CA |
| Country | United States |
$29/mo
Try RecallGuard →